Entyvio, manufactured by Takeda Pharmaceuticals, was approved in May 2014 for the treatment of adult patients with moderate to severe ulcerative colitis or Crohn's disease.
Study also highlights transitions-of-care programs that help patients avoid ED visits or acute care stays.
With the New Year approaching, let's resolve to decrease some of the difficulty with anticoagulant medications by welcoming patients and technology into the patient counseling dialogue.
This therapy is critical for the treatment of common disease states, including diabetes.
With new drugs in the pipeline and the impact of updated FDA drug safety policies on colchicine, gout may no longer be inexpensive to treat.
In outpatients with type 2 diabetes mellitus, persistent exenatide treatment lowered glycated hemoglobin and hyperglycemia in both genders. Waist circumference and body weight were more reduced in women.
An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.
With ongoing growth across the board, plan sponsors are continuously searching for ways to minimize the impact on their bottom line.
Eli Lilly and Company (NYSE: LLY) and AstraZeneca (NYSE: AZN) today announced that they have entered into a clinical trial collaboration to evaluate safety and preliminary efficacy of their products.
In the health-system setting, pharmacists must often prioritize their attention to treating the most acute medical condition a patient presents with; however, it is important to also consider opportunities to prevent disease.
It’s important that patients understand how their pharmacy can continue to meet their contraceptive needs during the coronavirus disease 2019 (COVID-19) pandemic.
This study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.
Ninety percent of diabetes cases are type 2, which is a major cause of morbidity and mortality.
Technology has become an essential part of health care.
Pradaxa (dabigatran etexilate) is the first oral direct thrombin inhibitor to be approved by the FDA.
Eravacycline, Omadacycline, Plazomicin, and a Rifamycin Add to the Armamentarium for Treating Resistant Infections
Each year, the National Academy of Medicine hosts its DC Public Health Case Challenge to promote interdisciplinary, problem-based learning that focuses on an important public health issue facing the Washington, DC community
Despite progress in reducing cancer mortality, more work is needed to improve patient outcomes in this disease state.
Data aggregation partners can provide value in their ability to pull clinical information from both the HSSP and electronic health records.
Educating patients about the nutrition facts label and integrating food pharmacies are examples of pharmacist opportunities.
As medication experts, pharmacists are integral to team-based care, providing the requisite knowledge for medication therapy management, as well as initiating, modifying and monitoring drug therapy to benefit patient care.